Search Results - Matthew Rabinowitz

Matthew Rabinowitz

Matthew Rabinowitz (born 4 February 1973) is a South African-American entrepreneur and investor. He is the co-founder and executive chairman of Natera (NTRA), a clinical genetic testing company. He serves as executive chairman, board member, adviser and angel investor to several companies and non-profits in diagnostics, biotech, machine learning, health services and nature conservation.

Rabinowitz has been a consulting professor in Aeronautics and Astronautics at Stanford University, visiting faculty in Genetics at Harvard Medical School. His technologies have generated over 100 patents and peer-reviewed publications. Provided by Wikipedia
  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    P659: Whole-genome sequencing as a first assay has the potential to shorten diagnosis time for neurodevelopmental disorders by Kate Im, Pauline Ng, Premal Shah, Matthew Rabinowitz, Brynn Levy, Akash Kumar

    Published in Genetics in Medicine Open (2023-01-01)
    Get full text
    Article


  2. 2

    P105: Assessing breast cancer risk: A comparative analysis of ancestry-adjusted PRS models in women of Ashkenazi Jewish heritage by Placede Tshiaba, Dariusz Ratman, Jiayi Sun, Jeffrey Weitzel, Premal Shah, Matthew Rabinowitz, Akash Kumar, Kate Im

    Published in Genetics in Medicine Open (2025-01-01)
    Get full text
    Article


  3. 3

    P333: Polygenic risk scores improve 10-year risk prediction of coronary artery disease in individuals at borderline and intermediate clinical risk* by Placede Tshiaba, Dariusz Ratman, Jiayi Sun, Tate Tunstall, Robert Maier, Premal Shah, Matthew Rabinowitz, Akash Kumar, Kate Im

    Published in Genetics in Medicine Open (2023-01-01)
    Get full text
    Article


  4. 4

    Implementation of Nanopore sequencing as a pragmatic workflow for copy number variant confirmation in the clinic by Stephanie U. Greer, Jacquelin Botello, Donna Hongo, Brynn Levy, Premal Shah, Matthew Rabinowitz, Danny E. Miller, Kate Im, Akash Kumar

    Published in Journal of Translational Medicine (2023-06-01)
    Get full text
    Article


  5. 5

    P314: Evaluating the clinical utility of a cross-ancestry integrated risk score for coronary artery disease prevention by Lindsay Meyers, Dariusz Ratman, Placede Tshiaba, Michael Levin, Jiayi Sun, Tate Tunstall, Robert Maier, Premal Shah, Matthew Rabinowitz, Daniel Rader, Akash Kumar, Kate Im

    Published in Genetics in Medicine Open (2025-01-01)
    Get full text
    Article


  6. 6

    102. Post-void Urethral Residual Volume and Lower Urinary Tract Symptoms Improve up to One Year Post-phalloplasty: A Prospective Cohort Study by Matthew Rabinowitz, BA, Jessica Mroueh, MD, Erik Reiche, MD, Vanessa Mroueh, MD, Lauren Eisenbeis, PA-C, James L. Liu, MD, Arthur L. Burnett, MD, Devin Coon, MD, MSE

    Get full text
    Article


  7. 7

    Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors by Ekaterina Kalashnikova, Vasily N. Aushev, Allyson Koyen Malashevich, Antony Tin, Shifra Krinshpun, Raheleh Salari, Carly Bess Scalise, Rosalyn Ram, Meenakshi Malhotra, Harini Ravi, Himanshu Sethi, Stephanie Sanchez, Robert Tanner Hagelstrom, Maxim Brevnov, Matthew Rabinowitz, Solomon Moshkevich, Bernhard G. Zimmermann, Minetta C. Liu, Alexey Aleshin

    Published in Molecular Oncology (2024-11-01)
    Get full text
    Article


Search Tools: